Steroid containing ophthalmic drug delivery systems

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/06 (2006.01) A61K 31/573 (2006.01)

Patent

CA 2700072

Pharmaceutical composition for intraocular use comprising a glucocorticoid derivative, such as beclomethasone 17, 21 -diproprionate admixed with a biodegradable polymer such as a poly(lactide- co-glycolide) polymer or a high molecular weight polymeric hyaluronic acid are disclosed.

Cette invention se rapporte à une composition pharmaceutique destinée à un usage intraoculaire comprenant un dérivé de glucocorticoïde, comme le béclométhasone 17, 21 -diproprionate mélangé avec un polymère biodégradable comme un poly(lactide-co-glycolide) ou un acide hyaluronique polymère de poids moléculaire élevé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Steroid containing ophthalmic drug delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Steroid containing ophthalmic drug delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid containing ophthalmic drug delivery systems will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1500661

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.